HeraMED (ASX:HMD) Operating Cash Flow per Share : A$-0.02 (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is HeraMED Operating Cash Flow per Share?

HeraMED's operating cash flow per share for the six months ended in Dec. 2023 was A$-0.01. HeraMED's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 10.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 21.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for HeraMED's Operating Cash Flow per Share or its related term are showing as below:

ASX:HMD' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 10.2 Med: 27.2 Max: 27.3
Current: 10.2

During the past 6 years, HeraMED's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.30% per year. The lowest was 10.20% per year. And the median was 27.20% per year.

ASX:HMD's 3-Year OCF Growth Rate is ranked better than
60.73% of 685 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs ASX:HMD: 10.20

HeraMED Operating Cash Flow per Share Historical Data

The historical data trend for HeraMED's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED Operating Cash Flow per Share Chart

HeraMED Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.04

-0.03

-0.02

HeraMED Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial						-0.01	-0.01	-0.01	-0.01	-0.01

Competitive Comparison of HeraMED's Operating Cash Flow per Share

For the Medical Devices subindustry, HeraMED's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeraMED's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HeraMED's Price-to-Operating-Cash-Flow falls into.

HeraMED Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

HeraMED's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-5.671	/	266.250
	=	-0.02

HeraMED's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-3.118	/	284.451
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.02

HeraMED Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of HeraMED's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

HeraMED (ASX:HMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (ASX:HMD) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

1I4:Germany

Address

4 Hazoran Street, POB 8576, Netanya, Netanya, ISR, 4250604

Website

https://www.hera-med.com

HeraMED Ltd is engaged in developing innovative, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heart beat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR).

HeraMED (ASX:HMD) Headlines

No Headlines